Skip to main content

Main menu

  • Home
  • Content
    • Current
      • JNMT Supplement
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI

User menu

  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
Journal of Nuclear Medicine Technology
  • SNMMI
    • JNMT
    • JNM
    • SNMMI Journals
    • SNMMI
  • Subscribe
  • My alerts
  • Log in
  • My Cart
Journal of Nuclear Medicine Technology

Advanced Search

  • Home
  • Content
    • Current
    • Ahead of print
    • Past Issues
    • Continuing Education
    • JNMT Podcast
    • SNMMI Annual Meeting Abstracts
  • Subscriptions
    • Subscribers
    • Rates
    • Journal Claims
    • Institutional and Non-member
  • Authors
    • Submit to JNMT
    • Information for Authors
    • Assignment of Copyright
    • AQARA Requirements
  • Info
    • Reviewers
    • Permissions
    • Advertisers
    • Corporate & Special Sales
  • About
    • About Us
    • Editorial Board
    • Contact Information
  • More
    • Alerts
    • Feedback
    • Help
    • SNMMI Journals
  • Watch or Listen to JNMT Podcast
  • Visit SNMMI on Facebook
  • Join SNMMI on LinkedIn
  • Follow SNMMI on Twitter
  • Subscribe to JNMT RSS feeds
Research ArticleContinuing Education

Practical Considerations for Implementation of 177Lu-DOTATATE Neuroendocrine Tumor Treatment Programs

Diane K. Soulek, Molly E. Martin, Nic J. Mastascusa and Stephen A. Graves
Journal of Nuclear Medicine Technology September 2022, 50 (3) 195-202; DOI: https://doi.org/10.2967/jnmt.122.263813
Diane K. Soulek
Department of Radiology, University of Iowa, Iowa City, Iowa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Molly E. Martin
Department of Radiology, University of Iowa, Iowa City, Iowa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Nic J. Mastascusa
Department of Radiology, University of Iowa, Iowa City, Iowa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
Stephen A. Graves
Department of Radiology, University of Iowa, Iowa City, Iowa
  • Find this author on Google Scholar
  • Find this author on PubMed
  • Search for this author on this site
  • Article
  • Figures & Data
  • Info & Metrics
  • PDF
Loading

Article Information

vol. 50 no. 3 195-202
DOI 
https://doi.org/10.2967/jnmt.122.263813
PubMed 
35701215

Published By 
Society of Nuclear Medicine
Print ISSN 
0091-4916
Online ISSN 
1535-5675
History 
  • Received for publication January 10, 2022
  • Accepted for publication June 8, 2022
  • Published online September 8, 2022.

Article Versions

  • previous version (June 14, 2022 - 10:37).
  • You are viewing the most recent version of this article.
Copyright & Usage 
© 2022 by the Society of Nuclear Medicine and Molecular Imaging.

Author Information

  1. Diane K. Soulek,
  2. Molly E. Martin,
  3. Nic J. Mastascusa and
  4. Stephen A. Graves
  1. Department of Radiology, University of Iowa, Iowa City, Iowa
  1. For correspondence or reprints, contact Diane Soulek (diane-soulek{at}uiowa.edu).
View Full Text

Statistics from Altmetric.com

Cited By...

  • Citations
  • Google Scholar

This article has not yet been cited by articles in journals that are participating in Crossref Cited-by Linking.

Article usage

Article usage: June 2022 to April 2025

AbstractFullPdf
Jun 2022472023
Jul 202223709
Aug 2022131014
Sep 2022356442237
Oct 2022215444253
Nov 2022165465218
Dec 2022110201203
Jan 2023134210197
Feb 202394130140
Mar 2023819335
Apr 2023565118
May 2023424016
Jun 2023495225
Jul 2023485426
Aug 2023484626
Sep 2023514625
Oct 2023529632
Nov 20233611820
Dec 20233218340
Jan 20242812042
Feb 20243111421
Mar 20242012641
Apr 20244440432
May 20242313948
Jun 20243214041
Jul 20243011635
Aug 20242210624
Sep 20243816653
Oct 20242523069
Nov 20244420953
Dec 20242117341
Jan 20252812286
Feb 20253323156
Mar 20252523446
Apr 20253028168
PreviousNext
Back to top

In this issue

Journal of Nuclear Medicine Technology: 50 (3)
Journal of Nuclear Medicine Technology
Vol. 50, Issue 3
September 1, 2022
  • Table of Contents
  • About the Cover
  • Index by author
  • Complete Issue (PDF)
Print
Download PDF
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word on Journal of Nuclear Medicine Technology.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
Practical Considerations for Implementation of 177Lu-DOTATATE Neuroendocrine Tumor Treatment Programs
(Your Name) has sent you a message from Journal of Nuclear Medicine Technology
(Your Name) thought you would like to see the Journal of Nuclear Medicine Technology web site.
Citation Tools
Practical Considerations for Implementation of 177Lu-DOTATATE Neuroendocrine Tumor Treatment Programs
Diane K. Soulek, Molly E. Martin, Nic J. Mastascusa, Stephen A. Graves
Journal of Nuclear Medicine Technology Sep 2022, 50 (3) 195-202; DOI: 10.2967/jnmt.122.263813

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Share
Practical Considerations for Implementation of 177Lu-DOTATATE Neuroendocrine Tumor Treatment Programs
Diane K. Soulek, Molly E. Martin, Nic J. Mastascusa, Stephen A. Graves
Journal of Nuclear Medicine Technology Sep 2022, 50 (3) 195-202; DOI: 10.2967/jnmt.122.263813
Twitter logo Facebook logo LinkedIn logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One
Bookmark this article

Jump to section

  • Article
    • Abstract
    • PATIENT SELECTION
    • CLINICAL CONSIDERATIONS
    • REGULATORY AND RADIATION SAFETY CONSIDERATIONS
    • PROTOCOL AND TECHNICAL CONSIDERATIONS
    • DOSIMETRY AND IMAGING
    • BILLING AND CODING
    • CONCLUSION
    • DISCLOSURE
    • ACKNOWLEDGMENTS
    • Footnotes
    • REFERENCES
  • Figures & Data
  • Info & Metrics
  • PDF

Related Articles

  • No related articles found.
  • PubMed
  • Google Scholar

Cited By...

  • Theranostics: The Future is Now!
  • Google Scholar

More in this TOC Section

  • Illuminating the Hidden: Standardizing Cardiac MIBG Imaging for Sympathetic Dysfunction
  • PET/CT Case Series: Unmasking the Mystery of Cardiac Sarcoidosis
  • Delivery Methods of Radiopharmaceuticals: Exploring Global Strategies to Minimize Occupational Radiation Exposure
Show more Continuing Education

Similar Articles

Keywords

  • neuroendocrine tumor
  • 177Lu-DOTATATE
  • somatostatin receptor
  • PRRT
  • dosimetry
SNMMI

© 2025 SNMMI

Powered by HighWire